Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

Author

O. Drapkina

h-index 14 View on Semantic Scholar

We have 4 of 126 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Association Between Plasma microRNA Levels and Major Adverse Cardiovascular Events in Participants from an Epidemiological Cohort

Circulating microRNAs (miRNAs) are promising biomarkers of cardiovascular disease (CVD) and three-point major adverse cardiovascular events (3P-MACE): CVD death, non-fatal myocardial infarction (MI), and non-fatal stroke. The associations between plasma miRNA levels and 3P-MACE in a prospective cohort from an epidemiol...

A. Kiseleva, Evgeniia A. Sotnikova, A. Zharikova et al. · 0 citations
Open access Aug 2026

Association of lipoprotein(a) with coronary artery calcium in Individuals without atherosclerotic cardiovascular disease

Aim . To evaluate the association between lipoprotein(a) [Lp(a)] levels and the presence and severity of coronary artery calcium (CAC) in patients without clinically established atherosclerotic cardiovascular disease (ASCVD). Material and methods . The study included1,777 outpatients without clinical manifestation...

Z. I. Khutaeva, G. Konovalov, M. Chashchin et al. · 0 citations
Review Open access Jul 2026

Analysis of biochemical markers in noninvasive assessment of mitochondrial dysfunction and mitochondrial health

Analysis of serum biomarkers associated with mitochondrial dysfunction and associated metabolic pathways, such as fibroblast growth factor-21 (FGF-21), growth differentiation factor 15 (GDF-15), peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α), neopterin, lactate, pyruvate, and ammonia, may serve as...

O. Drapkina, Yuriy S. Timofeev · 0 citations
Open access Jul 2026

Intrafamilial heterogeneity of clinical manifestations of a FBN1 gene variant in Marfan syndrome

This case demonstrates that a causative variant does not allow for a definitive prognosis of the disease course, and all carriers of the identified variant require regular multidisciplinary monitoring, regardless of the severity of clinical manifestations at the time of diagnosis.

E. Baranovskaya, A. Bukaeva, V. A. Rumyantseva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.